Cytokine gene polymorphisms in recurrent spontaneous abortions: A comprehensive review

American Journal of Reproductive Immunology

Volumn 60, Issue 2, 2008, Pages 91-110

  Choi, Yoon Kyong ^a,b   Kwak Kim, Joanne ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b Mirae and Heemang Ob/Gyn Clinic   (South Korea)

Author keywords

Cytokine; Genetic; Immune responses; Polymorphism; Recurrent spontaneous abortions; Spontaneous miscarriages; Th1 Th2

Indexed keywords

ADENINE; CYTOKINE; CYTOSINE; GAMMA INTERFERON; GUANINE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; THYMINE; TUMOR NECROSIS FACTOR ALPHA;

CYTOKINE PRODUCTION; DNA POLYMORPHISM; FACTORIAL ANALYSIS; GENE FREQUENCY; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; MEDLINE; NIDATION; POPULATION GENETICS; POPULATION RESEARCH; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; SPONTANEOUS ABORTION;

ABORTION, HABITUAL; CYTOKINES; FEMALE; HUMANS; POLYMORPHISM, GENETIC; PREGNANCY;

EID: 47949112088     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2008.00602.x     Document Type: Review

References (139)

1. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV: An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1-8.
2. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P: The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102: 1369-1376.
3. Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, McDermott MF, Oksenberg J, McNicholl J, Pociot F, Hardt C, D'Alfonso S: Cytokine gene polymorphism in human disease: On-line databases, supplement 1. Genes Immun 2001; 2: 61-70.
4. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D: Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508-510.
5. Daser A, Mitchison H, Mitchison A, Muller B: Non-classical-MHC genetics of immunological disease in man and mouse. The key role of pro-inflammatory cytokine genes. Cytokine 1996; 8: 593-597.
6. Wilkinson RJ, Patel P, Llewelyn M, Hirsch CS, Pasvol G, Snounou G, Davidson RN, Toossi Z: Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis. J Exp Med 1999; 189: 1863-1874.
7. Mrak R, Griffin W: Interleukin-1, neuroinflammation, and Alzheimer's disease. Neurobiol Aging 2001; 22: 903-908.
8. Hoffmann SC, Stanley EM, Darrin Cox E, Craighead N, DiMercurio BS, Koziol DE, Harlan DM, Kirk AD, Blair PJ: Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/ CD28-stimulated peripheral blood lymphocytes. Transplantation 2001; 72: 1444-1450.
9. Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ, Hutchinson IV: In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet 1999; 26: 1-3.
10. Rosenwasser LJ, Klemm DJ, Dresback JK, Inamura H, Mascali JJ, Klinnert M, Borish L: Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 1995; 25(Suppl. 2): 74-78.
11. Warle MC, Farhan A, Metselaar HJ, Hop WC, Perrey C, Zondervan PE, Kap M, Kwekkeboom J, Ijzermans JN, Tilanus HW, Pravica V, Hutchinson IV, Bouma GJ: Are cytokine gene polymorphisms related to in vitro cytokine production profiles? Liver Transpl 2003; 9: 170-181.
12. Wilson AG, di Giovine FS, Blakemore AI, Duff GW: Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992; 1: 353.
13. Lin MT, Storer B, Martin PJ, Tseng LH, Gooley T, Chen PJ, Hansen JA: Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med 2003; 349: 2201-2210.
14. Messer G, Spengler U, Jung MC, Honold G, Blomer K, Pape GR, Riethmuller G, Weiss EH: Polymorphic structure of the tumor necrosis factor (TNF) locus: An NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med 1991; 173: 209-219.
15. Regan L, Rai R: Epidemiology and the medical causes of miscarriage. Baillieres Best Pract Res Clin Obstet Gynaecol 2000; 14: 839-854.
16. Stephenson MD: Frequency of factors associated with habitual abortion in 197 couples. Fertil Steril 1996; 66: 24-29.
17. Kwak JY, Beaman KD, Gilman-Sachs A, Ruiz JE, Schewitz D, Beer AE: Up-regulated expression of CD56+, CD56+/CD16+, and CD19+ cells in peripheral blood lymphocytes in pregnant women with recurrent pregnancy losses. Am J Reprod Immunol 1995; 34: 93-99.
18. Kwak-Kim JY, Chung-Bang HS, Ng SC, Ntrivalas EI, Mangubat CP, Beaman KD, Beer AE, Gilman-Sachs A: Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod 2003; 18: 767-773.
19. Raghupathy R: Th1-type immunity is incompatible with successful pregnancy. Immunol Today 1997; 18: 478-482.
20. Wegmann TG, Lin H, Guilbert L, Mosmann TR: Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a TH2 phenomenon? Immunol Today 1993; 14: 353-356.
21. Raghupathy R, Makhseed M, Azizieh F, Hassan N, Al-Azemi M, Al-Shamali E: Maternal Th1- and Th2-type reactivity to placental antigens in normal human pregnancy and unexplained recurrent spontaneous abortions. Cell Immunol 1999; 196: 122-130.
22. Choudhury SR, Knapp LA: Human reproductive failure I: Immunological factors. Hum Reprod Update 2001; 7: 113-134.
23. Chen G, Wilson R, Wang SH, Zheng HZ, Walker JJ, McKillop JH: Tumour necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in pre-eclampsia. Clin Exp Immunol 1996; 104: 154-159.
24. Romero R, Mazor M, Sepulveda W, Avila C, Copeland D, Williams J: Tumor necrosis factor in preterm and term labor. Am J Obstet Gynecol 1992; 166: 1576-1587.
25. Marzi M, Vigano A, Trabattoni D, Villa ML, Salvaggio A, Clerici E, Clerici M: Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 1996; 106: 127-133.
26. MacLean MA, Wilson R, Thomson JA, Krishnamurthy S, Walker JJ: Changes in immunologic parameters in normal pregnancy and spontaneous abortion. Am J Obstet Gynecol 1991; 165: 890-895.
27. Hunt JS, Chen HL, Piller L: Tumor necrosis factors: pivotal components of pregnancy? Biol Reprod 1996; 54: 554-562.
28. Makhseed M, Raghupathy R, Azizieh F, Al-Azemi M, Hassan N, Bandar A: Mitogen-induced cytokine responses of maternal peripheral blood lymphocytes indicate a differential Th-type bias in normal pregnancy and pregnancy failure. Am J Reprod Immunol 1999; 42: 273-281.
29. Chaouat G, Menu E, Clark DA, Dy M, Minkowski M, Wegmann TG: Control of fetal survival in CBA × DBA/2 mice by lymphokine therapy. J Reprod Fertil 1990; 89: 447-458.
30. Clark DA, Chaouat G, Arck PC, Mittruecker HW, Levy GA: Cytokine-dependent abortion in CBA × DBA/2 mice is mediated by the procoagulant fgl2 prothrombinase [correction of prothombinase]. J Immunol 1998; 160: 545-549.
31. Yui J, Garcia-Lloret M, Wegmann TG, Guilbert LJ: Cytotoxicity of tumour necrosis factor-alpha and gamma-interferon against primary human placental trophoblasts. Placenta 1994; 15: 819-835.
32. Chaouat G, Assal Meliani A, Martal J, Raghupathy R, Elliott JF, Mosmann T, Wegmann TG: IL-10 prevents naturally occurring fetal loss in the CBA × DBA/2 mating combination, and local defect in IL-10 production in this abortion-prone combination is corrected by in vivo injection of IFN-tau. J Immunol 1995; 154: 4261-4268.
33. Kawamura K, Kawamura N, Kumagai J, Fukuda J, Tanaka T: Tumor necrosis factor regulation of apoptosis in mouse preimplantation embryos and its antagonism by transforming growth factor alpha/phosphatidylionsitol 3-kinase signaling system. Biol Reprod 2007; 76: 611-618.
34. Mosmann T, CoDfman R: TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145-173.
35. Romagnani S: Human THD and TH2 subsets: doubt no more. Immunol Today 1991; 12: 256-257.
36. Romagnani S: T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol 2000; 85: 9-18.
37. Piccinni M, Giudizi M, Biagiotti R, Beloni L, Giannarini L, Sampognaro S, Parronchi P, Manetti R, Annunziato F, Livi C: Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol 1995; 155: 128-133.
38. Piccinni M, Bani D, Beloni L, Manuelli C, Mavilia C, Vocioni F, Bigazzi M, Bani Sacchi T, Romagnani S, Maggi E: Relaxin favors the development of activated human T cells into Th1-like effectors. Eur J Immunol 1999; 29: 2241-2247.
39. Fortunato S, Menon R: IL-1 beta is a better inducer of apoptosis in human fetal membranes than IL-6. Placenta 2003; 24: 922-928.
40. Knackstedt M, Zenclussen A, Hertwig K, Hagen E, Dudenhausen J, Clark D, Arck P: Th1 cytokines and the prothrombinase fgl 2 in stress-triggered and inflammatory abortion. Am J Reprod Immunol 2003; 49: 210-220.
41. Chung I, Yelian F, Zaher F, Gonik B, Evans M, Diamond M, Svinarich D: Expression and regulation of vascular endothelial growth factor in a first trimester trophoblast cell line. Placenta 2000; 21: 320-324.
42. Ben-Yair E, Less A, Lev S, Ben-Yehoshua L, Tartakovsky B: Tumour necrosis factor alpha binding to human and mouse trophoblast. Cytokine 1997; 9: 830-836.
43. Jenkins C, Roberts J, Wilson R, MacLean MA, Shilito J, Walker JJ: Evidence of a T(H) 1 type response associated with recurrent miscarriage. Fertil Steril 2000; 73: 1206-1208.
44. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW: Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-3199.
45. Daher S, Fonseca F, Ribeiro O, Musatti C, Gerbase-DeLima M: Tumor necrosis factor during pregnancy and at the onset of labor and spontaneous abortion. Eur J Obstet Gynecol Reprod Biol 1999; 83: 77-79.
46. Ng SC, Gilman-Sachs A, Thaker P, Beaman KD, Beer AE, Kwak-Kim J: Expression of intracellular Th1 and Th2 cytokines in women with recurrent spontaneous abortion, implantation failures after IVF/ET or normal pregnancy. Am J Reprod Immunol 2002; 48: 77-86.
47. Mueller-Eckhardt G, Mallmann P, Neppert J, Lattermann A, Melk A, Heine O, Pfeiffer R, Zingsem J, Domke N, Mohr-Pennert A: Immunogenetic and serological investigations in nonpregnant and in pregnant women with a history of recurrent spontaneous abortions. German RSA/IVIG Study Group. J Reprod Immunol 1994; 27: 95-109.
48. Shaarawy M, Nagui A: Enhanced expression of cytokines may play a fundamental role in the mechanisms of immunologically mediated recurrent spontaneous abortion. Acta Obstet Gynecol Scand 1997; 76: 205-211.
49. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW: An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993; 177: 557-560.
50. Skoog T, van't Hooft FM, Kallin B, Jovinge S, Boquist S, Nilsson J, Eriksson P, Hamsten A: A common functional polymorphism (C->A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet 1999; 8: 1443-1449.
51. Moffatt MF, Cookson WO: Tumour necrosis factor haplotypes and asthma. Hum Mol Genet 1997; 6: 551-554.
52. Mycko M, Kowalski W, Kwinkowski M, Buenafe AC, Szymanska B, Tronczynska E, PlucienniczTk A, Selmaj K: Multiple sclerosis: the frequency of allelic forms of tumor necrosis factor and lymphotoxin-alpha. J Neuroimmunol 1998; 84: 198-206.
53. Nadel S, Newport MJ, Booy R, Levin M: Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis 1996; 174: 878-880.
54. Stuber F, Petersen M, Bokelmann F, Schade U: A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit Care Med 1996; 24: 381-384.
55. Daher S, Shulzhenko N, Morgun A, Mattar R, Rampim GF, Camano L, DeLima MG: Associations between cytokine gene polymorphisms and recurrent pregnancy loss. J Reprod Immunol 2003; 58: 69-77.
56. Pietrowski D, Bettendorf H, Keck C, Burkle B, Unfried G, Riener EK, Hefler LA, Tempfer C: Lack of association of TNFalpha gene polymorphisms and recurrent pregnancy loss in Caucasian women. J Reprod Immunol 2004; 61: 51-58.
57. Hefler LA, Tempfer CB, Unfried G, Schneeberger C, Lessl K, Nagele F, Huber JC: A polymorphism of the interleukin-1beta gene and idiopathic recurrent miscarriage. Fertil Steril 2001; 76: 377-379.
58. Babbage SJ, Arkwright PD, Vince GS, Perrey C, Pravica V, Quenby S, Bates M, Hutchinson IV: Cytokine promoter gene polymorphisms and idiopathic recurrent pregnancy loss. J Reprod Immunol 2001; 51: 21-27.
59. Prigoshin N, Tambutti M, Larriba J, Gogorza S, Testa R: Cytokine gene polymorphisms in recurrent pregnancy loss of unknown cause. Am J Reprod Immunol 2004; 52: 36-41.
60. Kamali-Sarvestani E, Zolghadri J, Gharesi-Fard B, Sarvari J: Cytokine gene polymorphisms and susceptibility to recurrent pregnancy loss in Iranian women. J Reprod Immunol 2005; 65: 171-178.
61. Simon C, Piquette G, Frances A, Polan M: Localization of interleukin-1 type I receptor and interleukin-1 beta in human endometrium throughout the menstrual cycle. J Clin Endocrinol Metab 1993; 77: 549-555.
62. Simon C, Gimeno M, Mercader A, O'Connor J, Remoh IJ, Polan M, Pellicer A: Embryonic regulation of integrins ß3, alpha 4, and alpha 1 in human endometrial epithelial cells in vitro. J Clin Endocrinol Metab 1997; 82: 2607-2616.
63. Meisser A, Chardonnens D, Campana A, Bischof P: Effects of tumour necrosis factor-alpha, interleukin-1 alpha, macrophage colony stimulating factor and transforming growth factor ß on trophoblastic matrix metalloproteinases. Mol Hum Reprod 1999; 5: 252-260.
64. Laird S, Tuckerman E, Dalton C, Dunphy B, Li T, Zhang X: The production of leukaemia inhibitory factor by human endometrium: Presence in uterine flushings and production by cells in culture. Hum Reprod 1997; 12: 569-574.
65. Simon C, Valbuena D, Krussel J, Bernal A, Murphy CR, Shaw T, Pellicer A, Polan ML: Interleukin-1 receptor antagonist prevents embryonic implantation by a direct effect on the endometrial epithelium. Fertil Steril 1998; 70: 896-906.
66. Robertson SA, Seamark RF, Guilbert LJ, Wegmann TG: The role of cytokines in gestation. Crit Rev Immunol 1994; 14: 239-292.
67. Lichtman AH, Chin J, Schmidt JA, Abbas AK: Role of interleukin 1 in the activation of T lymphocytes. Proc Natl Acad Sci U S A 1988; 85: 9699-9703.
68. Manetti R, Barak V, Piccinni MP, Sampognaro S, Parronchi P, Maggi E, Dinarello CA, Romagnani S: Interleukin-1 favours the in vitro development of type 2 T helper (Th2) human T-cell clones. Res Immunol 1994; 145: 93-100.
69. Oriss TB, McCarthy SA, Morel BF, Campana MA, Morel PA: Crossregulation between T helper cell (Th)1 and Th2: Inhibition of Th2 proliferation by IFN-gamma involves interference with IL-1. J Immunol 1997; 158: 3666-3672.
70. Huber M, Rutherford A, Meister W, Weiss A, Rollinghoff M, Lohoff M: TCR- and IL-1-mediated co-stimulation reveals an IL-4-independent way of Th2 cell proliferation. Int Immunol 1996; 8: 1257-1263.
71. Hunter CA, Chizzonite R, Remington JS: IL-1 beta is required for IL-12 to induce production of IFN-gamma by NK cells. A role for IL-1 beta in the T cell-independent mechanism of resistance against intracellular pathogens. J Immunol 1995; 155: 4347-4354.
72. Tominaga K, Yoshimoto T, Torigoe K, Kurimoto M, Matsui K, Hada T, Okamura H, Nakanishi K: IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells. Int Immunol 2000; 12: 151-160.
73. Dinarello C: InflaImatory cytokines: interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases. Curr Opin Immunol 1991; 3: 941-948.
74. Bioque G, Crusius J, Koutroubakis I, Bouma G, Kostense P, Meuwissen S, Pena A: Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin Exp Immunol 1995; 102: 379-383.
75. Librach CL, Feigenbaum SL, Bass KE, Cui TY, Verastas N, Sadovsky Y, Quigley JP, French DL, Fisher SJ: Interleukin-1 beta regulates human cytotrophoblast metalloproteinase activity and invasion in vitro. J Biol Chem 1994; 269: 17125-17131.
76. von Wolff M, Thaler CJ, Strowitzki T, Broome J, Stolz W, Tabibzadeh S: Regulated expression of cytokines in human endometrium throughout the menstrual cycle: Dysregulation in habitual abortion. Mol Hum Reprod 2000; 6: 627-634.
77. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF Jr, Rabkin CS: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398-402.
78. di Giovine FS, Takhsh E, Blakemore AI, Duff GW: Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Hum Mol Genet 1992; 1: 450.
79. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J: A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992; 22: 396-402.
80. Wang ZC, Yunis EJ, De los Santos MJ, Xiao L, Anderson DJ, Hill JA: T helper 1-type immunity to trophoblast antigens in women with a history of recurrent pregnancy loss is associated with polymorphism of the IL1B promoter region. Genes Immun 2002; 3: 38-42.
81. Hefler LA, Tempfer CB, Bashford MT, Unfried G, Zeillinger R, Schneeberger C, Koelbl H, Nagele F, Huber JC: Polymorphisms of the angiotensinogen gene, the endothelial nitric oxide synthase gene, and the interleukin-1 beta gene promoter in women with idiopathic recurrent miscarriage. Mol Hum Reprod 2002; 8: 95-100.
82. Linjawi S, Li T-C, Laird S, Blakemore A: Interleukin-1 receptor antagonist and interleukin-1 beta polymorphisms in women with recurrent miscarriage. Fertil Steril 2005; 83: 1549-1552.
83. Reid JG, Simpson NA, Walker RG, Economidou O, Shillito J, Gooi HC, Duffy SR, Walker JJ: The carriage of pro-inflammatory cytokine gene polymorphisms in recurrent pregnancy loss. Am J Reprod Immunol 2001; 45: 35-40.
84. Khani-Hanjani A, Lacaille D, Hoar D, Chalmers A, Horsman D, Anderson M, Balshaw R, Keown PA: Association between dinucleotide repeat in non-coding region of interferon-gamma gene and susceptibility to, and severity of, rheumatoid arthritis. Lancet 2000; 356: 820-825.
85. Nemetz A, Nosti-Escanilla MP, Molnar T, Kope A, Kovacs A, Feher J, Tulassay Z, Nagy F, Garcia-Gonzalez MA, Pena AS: IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease. Immunogenetics 1999; 49: 527-531.
86. Santtila S, Savinainen K, Hurme M: Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol 1998; 47: 195-198.
87. Dinarello C: Biologic basis for interleukin-1 in disease. Blood 1996; 87: 2095-2147.
88. Tarlow J, Blakemore A, Lennard A, Solari R, Hughes H, Steinkasserer A, Duff G: Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993; 91: 403-404.
89. Mansfield J, Holden H, Tarlow J, Di Giovine F, McDowell T, Wilson A, Holdsworth C, Duff G: Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994; 106: 637-642.
90. Crusius J, Pena A, Van Oosten B, Bioque G, Garcia A, Dijkstra C, Polman C: Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis. Lancet 1995; 346: 979.
91. Blakemore A, Cox A, Gonzalez A, Maskill J, Hughes M, Wilson R, Ward J, Duff G: Interleukin-1 receptor antagonist allele (ILIRN* 2) associated with nephropathy in diabetes mellitus. Hum Genet 1996; 97: 369-374.
92. Tarlow J, Clay F, Cork M, Blakemore A, McDonagh A, Messenger A, Duff G: Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. J Invest Dermatol 1994; 103: 387-390.
93. Danis V, Millington M, Hland V, Grenan D: Cytokine production by monocytes: Intersubject variation and relationship to an IL-1ra gene polymorphism. Clin Exp Immunol 1995; 99: 303-310.
94. Karhukorpi J, Laitinen T, Kivela H, Tiilikainen A, Hurme M: IL-1 receptor antagonist gene polymorphism in recurrent spontaneous abortion. J Reprod Immunol 2003; 58: 61-67.
95. Mout R, Willemze R, Landegent J: Repeat polymorphisms in the interleukin-4 gene (IL4). Nucleic Acids Res 1991; 19: 3763.
96. Arai N: Complete nucleotide sequence of the chromosomal gene for human IL-4 and its expression. J Immunol 1989; 142: 274-282.
97. Vandenbroeck K, Martino G, Marrosu M, Consiglio A, Zaffaroni M, Vaccargiu S, Franciotta D, Ruggeri M, Comi G, Grimaldi L: Occurrence and clinical relevance of an interleukin-4 gene polymorphism in patients with multiple sclerosis. J Neuroimmunol 1997; 76: 189-192.
98. Buchs N, Silvestri T, di Giovine F, Chabaud M, Vannier E, Duff G, Miossec P: IL-4 VNTR gene polymorphism in chronic polyarthritis. The rare allele is associated with protection against destruction. Rheumatology 2000; 39: 1126-1131.
99. Masutani K, Miyake K, Nakashima H, Hirano T, Kubo M, Hirakawa M, Tsuruya K, Fukuda K, Kanai H, Otsuka T: Impact of interferon-gamma and interleukin-4 gene polymorphisms on development and progression of IgA nephropathy in Japanese patients. Am J Kidney Dis 2003; 41: 371-379.
100. Saijo Y, Sata F, Yamada H, Konodo T, Kato EH, Kataoka S, Shimada S, Morikawa M, Minakami H, Kishi R, Prigoshin N, Tambutti M, Larriba J, Gogorza S, Testa R, Pietrowski D, Bettendorf H, Keck C, Burkle B, Unfried G, Riener EK, Hefler LA, Tempfer C: Interleukin-4 gene polymorphism is not involved in the risk of recurrent pregnancy loss. Am J Reprod Immunol 2004; 52: 143-146.
101. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP: The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998; 128: 127-137.
102. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, Achong MK: IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998; 101: 311-320.
103. Koumantaki Y, Matalliotakis I, Sifakis S, Kyriakou D, Neonaki M, Goymenou A, Koumantakis E: Detection of interleukin-6, interleukin-8, and interleukin-11 in plasma from women with spontaneous abortion. Eur J Obstet Gynecol Reprod Biol 2001; 98: 66-71.
104. Arntzen KJ, Lien E, Austgulen R: Maternal serum levels of interleukin-6 and clinical characteristics of normal delivery at term. Acta Obstet Gynecol Scand 1997; 76: 55-60.
105. Olah KS, Vince GS, Neilson JP, Deniz G, Johnson PM: Interleukin-6, interferon-gamma, interleukin-8, and granulocyte-macrophage colony stimulating factor levels in human amniotic fluid at term. J Reprod Immunol 1996; 32: 89-98.
106. Imseis HM, Greig PC, Livengood CH III, Shunior E, Durda P, Erikson M: Characterization of the inflammatory cytokines in the vagina during pregnancy and labor and with bacterial vaginosis. J Soc Gynecol Investig 1997; 4: 90-94.
107. Steinborn A, Gunes H, Roddiger S, Halberstadt E: Elevated placental cytokine release, a process associated with preterm labor in the absence of intrauterine infection. Obstet Gynecol 1996; 88: 534-539.
108. Gravett MG, Witkin SS, Haluska GJ, Edwards JL, Cook MJ, Novy MJ: An experimental model for intraamniotic infection and preterm labor in rhesus monkeys. Am J Obstet Gynecol 1994; 171: 1660-1667.
109. Siiteri PK, Febres F, Clemens LE, Chang RJ, Gondos B, Stites D: Progesterone and maintenance of pregnancy: Is progesterone nature's immunosuppressant? Ann N Y Acad Sci 1977; 286: 384-397.
110. Nishino E, Matsuzaki N, Masuhiro K, Kameda T, Taniguchi T, Takagi T, Saji F, Tanizawa O: Trophoblast-derived interleukin-6 (IL-6) regulates human chorionic gonadotropin release through IL-6 receptor on human trophoblasts. J Clin Endocrinol Metab 1990; 71: 436-441.
111. Romero R, Avila C, Santhanam U, Sehgal PB: Amniotic fluid interleukin 6 in preterm labor. Association with infection. J Clin Invest 1990; 85: 1392-1400.
112. Fukuda H, Masuzaki H, Ishimaru T: Interleukin-6 and interleukin-1 receptor antagonist in amniotic fluid and cord blood in patients with pre-term, premature rupture of the membranes. Int J Gynaecol Obstet 2002; 77: 123-129.
113. Fernandez-Real JM, Broch M, Vendrell J, Richart C, Ricart W: Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. J Clin Endocrinol Metab 2000; 85: 1334-1339.
114. Ota N, Nakajima T, Nakazawa I, Suzuki T, Hosoi T, Orimo H, Inoue S, Shirai Y, Emi M: A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density. J Hum Genet 2001; 46: 267-272.
115. Unfried G, Bocskor S, Endler G, Nagele F, Huber JC, Tempfer CB: A polymorphism of the interleukin-6 gene promoter and idiopathic recurrent miscarriage. Hum Reprod 2003; 18: 267-270.
116. Saijo Y, Sata F, Yamada H, Kondo T, Kato EH, Kishi R: Single nucleotide polymorphisms in the promoter region of the interleukin-6 gene and the risk of recurrent pregnancy loss in Japanese women. Fertil Steril 2004; 81: 374-378.
117. Hayakawa T, Takamura T, Hisada A, Abe T, Nomura G, Kobayashi K: IL-6 gene polymorphism -174G/C does not contribute substantially to hyperlipidaemia and type II diabetes mellitus in Japanese men. Diabetologia 2002; 45: 453-454.
118. Zhai R, Liu G, Yang C, Huang C, Wu C, Christiani DC: The G to C polymorphism at -174 of the interleukin-6 gene is rare in a Southern Chinese population. Pharmacogenetics 2001; 11: 699-701.
119. Lim CS, Zheng S, Kim YS, Ahn C, Han JS, Kim S, Lee JS, Chae DW: The -174 G to C polymorphism of interleukin-6 gene is very rare in Koreans. Cytokine 2002; 19: 52-54.
120. Hanna N, Hanna I, Hleb M, Wagner E, Dougherty J, Balkundi D, Padbury J, Sharma S: Gestational age-dependent expression of IL-10 and its receptor in human placental tissues and isolated cytotrophoblasts. J Immunol 2000; 164: 5721-5728.
121. Dealtry GB, O'Farrell MK, Fernandez N: The Th2 cytokine environment of the placenta. Int Arch Allergy Immunol 2000; 123: 107-119.
122. Fiorentino DF, Bond MW, Mosmann TR: Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170: 2081-2095.
123. Hanlon AM, Jang S, Salgame P: Signaling from cytokine receptors that affect Th1 responses. Front Biosci 2002; 7: D1247-d1254.
124. Piccinni MP, Beloni L, Livi C, Maggi E, Scarselli G, Romagnani S: Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat Med 1998; 4: 1020-1024.
125. Temple SE, Lim E, Cheong KY, Almeida CA, Price P, Ardlie KG, Waterer GW: Alleles carried at positions -819 and -592 of the IL10 promoter affect transcription following stimulation of peripheral blood cells with Streptococcus pneumoniae. Immunogenetics 2003; 55: 629-632.
126. Karhukorpi J, Laitinen T, Karttunen R, Tiilikainen AS: The functionally important IL-10 promoter polymorphism (-1082G->A) is not a major genetic regulator in recurrent spontaneous abortions. Mol Hum Reprod 2001; 7: 201-203.
127. Daher S, Denardi KDAG, Blotta MHSL, Mamoni RL, Reck APM, Camano L, Mattar R: Cytokines in recurrent pregnancy loss. J Reprod Immunol 2004; 62: 151-157.
128. Vassiliadis S, Ranella A, Papadimitriou L, Makrygiannakis A, Athanassakis I: Serum levels of pro- and anti-inflammatory cytokines in non-pregnant women, during pregnancy, labour and abortion. Mediators Inflamm 1998; 7: 69-72.
129. Makhseed M, Raghupathy R, Azizieh F, Farhat R, Hassan N, Bandar A: Circulating cytokines and CD30 in normal human pregnancy and recurrent spontaneous abortions. Hum Reprod 2000; 15: 2011-2017.
130. Heyborne KD, McGregor JA, Henry G, Witkin SS, Abrams JS: Interleukin-10 in amniotic fluid at midtrimester: Immune activation and suppression in relation to fetal growth. Am J Obstet Gynecol 1994; 171: 55-59.
131. Roth I, Fisher SJ: IL-10 is an autocrine inhibitor of human placental cytotrophoblast MMP-9 production and invasion. Dev Biol 1999; 205: 194-204.
132. Mallmann P, Mallmann R, Krebs D: Determination of tumor necrosis factor alpha (TNFa) and Interleukin 2 (IL2) in women with idiopathic recurrent miscarriage. Arch Gynecol Obstet 1991; 249: 73-78.
133. Almawi W, Irani-Hakime N: The antiproliferative effect of glucocorticoids: Is it related to induction of TGF-beta? Nephrol Dial Transplant 1998; 13: 2450-2452.
134. Hutchinson I, Pravica V, Hajeer A, Sinnott P: Identification of high and low responders to allografts. Rev Immunogenet 1999; 1: 323-333.
135. Lin H, Mosmann T, Guilbert L, Tuntipopipat S, Wegmann T: Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol 1993; 151: 4562-4573.
136. Fukui A, Kwak-Kim J, Ntrivalas E, Gilman-Sachs A, Lee SK, Beaman K: Intracellular cytokine expression of peripheral blood natural killer cell subsets in women with recurrent spontaneous abortions and implantation failures. Fertil Steril 2007; 89: 157-165.
137. Unfried G, Tempfer C, Schneeberger C, Widmar B, Nagele F, Huber JC: Interleukin 1 receptor antagonist polymorphism in women with idiopathic recurrent miscarriage. Fertil Steril 2001; 75: 683-687.
138. Manchanda PK, Bid HK, Mittal RD: Ethnicity greatly influences the interleukin-1 gene cluster(IL-1b promoter, exon-5 and IL-1Ra) polymorphisms: A pilot study of a north Indian population. Asian Pac J Cancer Prev 2005; 6: 541-546.
139. Baxter N, Sumiya M, Cheng S, Erlich H, Regan L, Simons A, Summerfield JA: Recurrent miscarriage and variant alleles of mannose binding lectin, tumour necrosis factor and lymphotoxin alpha genes. Clin Exp Immunol 2001; 126: 529-534.